STOCK TITAN

[Form 4] COHEN & STEERS, INC. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Reena Aggarwal, a director of Cohen & Steers, Inc. (CNS), reported a stock award transaction dated 10/01/2025. The filing shows acquisition of 423 shares of common stock resulting from restricted stock units granted by the issuer at a $0 per-share price, and the reporting person holds 16,185 shares following the transaction. The RSUs were 100% vested on the grant date, with the underlying shares to be delivered on the third anniversary of the grant date. The Form 4 was filed by one reporting person and signed on behalf of the reporting person by an attorney-in-fact on 10/03/2025.

Reena Aggarwal, una direttrice di Cohen & Steers, Inc. (CNS), ha riportato una transazione di premio azionario datata 10/01/2025. La pratica mostra l'acquisizione di 423 azioni ordinarie derivanti da unità azionarie limitate concesse dall'emittente a un prezzo per azione di $0, e la persona che segnala detiene 16.185 azioni dopo la transazione. Le RSU erano 100% vestite al momento della concessione, con le azioni sottostanti da consegnare al terzo anniversario della data di concessione. Il modulo 4 è stato presentato da una persona segnalante e firmato per conto della stessa da un procuratore in fact il 03/10/2025.

Reena Aggarwal, una directora de Cohen & Steers, Inc. (CNS), informó una transacción de asignación de acciones con fecha 10/01/2025. El registro muestra la adquisición de 423 acciones comunes resultantes de unidades de acciones restringidas otorgadas por el emisor a un precio de $0 por acción, y la persona que informa posee 16,185 acciones tras la transacción. Las RSU estaban 100% vestidas en la fecha de otorgamiento, con las acciones subyacentes que serán entregadas en el tercé aniversario de la fecha de otorgamiento. El Formulario 4 fue presentado por una persona informante y firmado en nombre de la persona informante por un apoderado el 03/10/2025.

Reena AggarwalCohen & Steers, Inc. (CNS)이사로서 10/01/2025에 dated 주식 수여 거래를 보고했습니다. 공시에는 발행인이 부여한 제한 주식 단위로 인해 423주 일반주식을 취득한 것이 나타나며, 보고자는 거래 후 16,185주를 보유합니다. RSU는 부여일에 100% 취득되었고, 기초 주식은 부여일로부터의 세 번째 기념일에 인도될 예정입니다. 양식 4는 한 명의 보고자에 의해 제출되었고, 10/03/2025에 보고자를 대신해 대리인에 의해 서명되었습니다.

Reena Aggarwal, une directrice de Cohen & Steers, Inc. (CNS), a déclaré une transaction d'attribution d'actions datée du 01/10/2025. Le dossier montre l'acquisition de 423 actions ordinaires résultant d'unités d'actions restreintes accordées par l'émetteur à un prix par action de $0, et la personne déclarante détiendra 16 185 actions après la transaction. Les RSU étaient à 100% acquises à la date d'octroi, les actions sous-jacentes devant être livrées au troisième anniversaire de la date d'octroi. Le Formulaire 4 a été déposé par une personne déclarante et signé au nom de la personne déclarante par un mandataire à partir du 03/10/2025.

Reena Aggarwal, eine Direktorin von Cohen & Steers, Inc. (CNS), hat eine Transaktion zur Aktienzuteilung mit dem Datum 10/01/2025 gemeldet. Die Einreichung zeigt den Erwerb von 423 Stammaktien, der aus Restricted Stock Units resultiert, die vom Emittenten zu einem $0 pro Aktie gewährt wurden, und die meldende Person hält nach der Transaktion 16.185 Aktien. Die RSUs waren zum Ausgabedatum zu 100% vestet, und die darunter liegenden Aktien werden am dritten Jubiläum des Ausgabedatums geliefert. Das Formular 4 wurde von einer meldenden Person eingereicht und am 10/03/2025 von einem Bevollmächtigten im Namen der meldenden Person unterzeichnet.

ريـنا أغاروال، مديرة في Cohen & Steers, Inc. (CNS)، أبلغت عن معاملة منحة أسهم بتاريخ 10/01/2025. يظهر التسجيل اكتساب 423 سهمًا من الأسهم العادية نتيجة وحدات الأسهم المقيدة الممنوحة من المصدر، وبناء عليه أصبح لدى الشخص المبلغ عنبن 16,185 سهماً بعد المعاملة. كانت RSUs مكتملة الاستحقاق 100% في تاريخ المنح، مع الأسهم الأساسية ستُسلم في الذكرى الثالثة لتاريخ المنح. تم تقديم النموذج 4 من قِبل شخص واحد مُبلغ عنه وتوقيعه نيابة عن الشخص المبلغ عنه من قِبل وكيـل تنفيذ في 10/03/2025.

Reena AggarwalCohen & Steers, Inc. (CNS)董事,报告了日期为 2025/10/01 的股票奖励交易。申报显示因发行人授予的限制性股票单位而获得423股普通股,交易后申报人持有16,185股。RSU 在授予日100%完成归属,相关股票将在授予日的第三周年交付。Form 4 由一名申报人提交,并在2025/10/03由代理人代表申报人签署。

Positive
  • 423 shares acquired via RSUs that were 100% vested on grant date
  • Total beneficial ownership reported at 16,185 shares, showing significant director holding
Negative
  • None.

Insights

Director received vested RSUs totaling 423 shares; delivery delayed until third anniversary.

The report documents a non-cash equity award: 423 common shares underlying restricted stock units were granted and are 100% vested on the grant date, indicating no further vesting condition. The award price is listed as $0, consistent with company compensation grants rather than open-market purchases.

Because the shares are payable on the third anniversary of the grant date, the reporting person does not yet hold these shares outright, though the award increases future potential dilution and aligns the director’s compensation with shareholder outcomes. The filing shows total beneficial ownership of 16,185 shares after the reported transaction.

Reena Aggarwal, una direttrice di Cohen & Steers, Inc. (CNS), ha riportato una transazione di premio azionario datata 10/01/2025. La pratica mostra l'acquisizione di 423 azioni ordinarie derivanti da unità azionarie limitate concesse dall'emittente a un prezzo per azione di $0, e la persona che segnala detiene 16.185 azioni dopo la transazione. Le RSU erano 100% vestite al momento della concessione, con le azioni sottostanti da consegnare al terzo anniversario della data di concessione. Il modulo 4 è stato presentato da una persona segnalante e firmato per conto della stessa da un procuratore in fact il 03/10/2025.

Reena Aggarwal, una directora de Cohen & Steers, Inc. (CNS), informó una transacción de asignación de acciones con fecha 10/01/2025. El registro muestra la adquisición de 423 acciones comunes resultantes de unidades de acciones restringidas otorgadas por el emisor a un precio de $0 por acción, y la persona que informa posee 16,185 acciones tras la transacción. Las RSU estaban 100% vestidas en la fecha de otorgamiento, con las acciones subyacentes que serán entregadas en el tercé aniversario de la fecha de otorgamiento. El Formulario 4 fue presentado por una persona informante y firmado en nombre de la persona informante por un apoderado el 03/10/2025.

Reena AggarwalCohen & Steers, Inc. (CNS)이사로서 10/01/2025에 dated 주식 수여 거래를 보고했습니다. 공시에는 발행인이 부여한 제한 주식 단위로 인해 423주 일반주식을 취득한 것이 나타나며, 보고자는 거래 후 16,185주를 보유합니다. RSU는 부여일에 100% 취득되었고, 기초 주식은 부여일로부터의 세 번째 기념일에 인도될 예정입니다. 양식 4는 한 명의 보고자에 의해 제출되었고, 10/03/2025에 보고자를 대신해 대리인에 의해 서명되었습니다.

Reena Aggarwal, une directrice de Cohen & Steers, Inc. (CNS), a déclaré une transaction d'attribution d'actions datée du 01/10/2025. Le dossier montre l'acquisition de 423 actions ordinaires résultant d'unités d'actions restreintes accordées par l'émetteur à un prix par action de $0, et la personne déclarante détiendra 16 185 actions après la transaction. Les RSU étaient à 100% acquises à la date d'octroi, les actions sous-jacentes devant être livrées au troisième anniversaire de la date d'octroi. Le Formulaire 4 a été déposé par une personne déclarante et signé au nom de la personne déclarante par un mandataire à partir du 03/10/2025.

Reena Aggarwal, eine Direktorin von Cohen & Steers, Inc. (CNS), hat eine Transaktion zur Aktienzuteilung mit dem Datum 10/01/2025 gemeldet. Die Einreichung zeigt den Erwerb von 423 Stammaktien, der aus Restricted Stock Units resultiert, die vom Emittenten zu einem $0 pro Aktie gewährt wurden, und die meldende Person hält nach der Transaktion 16.185 Aktien. Die RSUs waren zum Ausgabedatum zu 100% vestet, und die darunter liegenden Aktien werden am dritten Jubiläum des Ausgabedatums geliefert. Das Formular 4 wurde von einer meldenden Person eingereicht und am 10/03/2025 von einem Bevollmächtigten im Namen der meldenden Person unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Aggarwal Reena

(Last) (First) (Middle)
1166 AVENUE OF THE AMERICAS

(Street)
NEW YORK NY 10036

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
COHEN & STEERS, INC. [ CNS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/01/2025 A 423(1) A $0 16,185 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents shares of common stock underlying restricted stock units granted by the issuer to the reporting person. Such restricted stock units were 100% vested on the grant date and the related number of shares will be delivered to the reporting person on the third anniversary of the grant date.
Remarks:
/s/ Brian W. Heller, Attorney-in-Fact 10/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Form 4 filed for CNS disclose?

The Form 4 shows director Reena Aggarwal acquired 423 shares via restricted stock units on 10/01/2025, increasing her beneficial ownership to 16,185 shares.

Were the restricted stock units vested or subject to future vesting?

The filing states the RSUs were 100% vested on the grant date and the related shares will be delivered on the third anniversary of the grant.

What price was paid for the acquired shares reported on Form 4?

The transaction lists a per-share price of $0, indicating the shares derive from a compensation grant rather than an open-market purchase.

Who signed the Form 4 and when was it signed?

The Form 4 was signed on behalf of the reporting person by Brian W. Heller, Attorney-in-Fact on 10/03/2025.

Does the filing indicate multiple reporting persons filed the Form 4?

No. The form indicates it was filed by one reporting person.
Cohen & Steers Inc

NYSE:CNS

CNS Rankings

CNS Latest News

CNS Latest SEC Filings

CNS Stock Data

3.32B
27.43M
46.02%
60.33%
3.88%
Asset Management
Investment Advice
Link
United States
NEW YORK